Thursday, August 15, 2019 1:52:02 AM
https://mjbizdaily.com/florida-medical-marijuana-edible-sales/
April 2019
Florida’s agriculture department finalized its rules for medical marijuana growers around edibles, which brings the Sunshine State one step closer to allowing sales of the popular products.
The state is expected to allow sales of edibles in the coming months.
The Florida health department, which regulates the state’s MMJ industry, must still issue the proposed rules and seek public input, according to Orlando public radio station WFME.
For more details about the situation, click here.
Southeast Edibles.” First Foods has been eagerly anticipating the legalization of hemp-based products in the state of Florida, Aug 13 PR
https://cannabisnow.com/canada-is-getting-edibles-in-december/
Dec 2019 Edibles in Canada
June 2018 , still relevant:
https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms
The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.
How Does CBD Affect the Endocannabinoid System?
Recent science has found that the endocannabinoid system does not just respond to the endocannabinoids produced in the body, but also respond to external cannabinoids like the phytocannabinoid cannabidiol, or CBD. Introducing CBD to the body can help reduce the symptoms of a wide range of illnesses including epilepsy, multiple sclerosis, chronic inflammation, depression, diabetes, rheumatoid arthritis, anxiety, and opioid withdrawal.
By stimulating the endocannabinoid system, CBD promotes homeostasis, reduces pain sensation and decreases inflammation.
who removed all the walgreens stickies? mmmm
Recent EDXC News
- Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • InvestorsHub NewsWire • 03/27/2024 07:01:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM